Small Bone Innovations Inc.
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.
Orthopedic technology company Small Bone Innovations Inc. landed a $43 million loan to further sales of its flagship ankle replacement device.
The New York-based company plans to use the credit facility as working capital to drive U.S. growth of its Star total ankle replacement, a non-cemented implant designed to replace arthritic ankle joints in patients with osteoarthritis, post-traumatic arthritis or rheumatoid arthritis.
The system is currently the only mobile-bearing total ankle replacement approved for the U.S. market.
Cynosure Inc. (NSDQ:CYNO) officials said the company has won international regulatory approval for two of its cellulite reduction systems, including the SmoothShapes laser liposuction device that sucked $40 million out of now-defunct Elemé Medical Inc.
The FDA granted Boston Scientific Corp. (NYSE:BSX) approval for its anchoring device for the company’s spinal cord stimulator (SCS) implant system.
The Natick, Mass.-based medical device giant designed its new Clik Anchor with locking system to increase the speed with which surgeons place the Precision Plus SCS system’s leads — the wires through which pain-masking electrical pulses are delivered to the spine for chronic pain management.